Buy One Get One free -Llimited Time Offer X
Cilacar TC 6.25 Tablet is a prescription drug, available for use as Tablet. Other than this, Cilacar TC 6.25 Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Cilacar TC 6.25 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Cilacar TC 6.25 Tablet also has some side effects, the most common being Back Pain, Loss of appetite, Gastric Irritation. While these are the most often observed Cilacar TC 6.25 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Cilacar TC 6.25 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Cilacar TC 6.25 Tablet's effect during pregnancy is Mild and Mild while nursing. Further, the section on Cilacar TC 6.25 Tablet related warnings talks about Cilacar TC 6.25 Tablet's effects on the liver, heart and kidney.
Cilacar TC 6.25 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia as it can result in adverse effects. Other contraindications of Cilacar TC 6.25 Tablet have been discussed in the sections ahead.
Drug reaction of Cilacar TC 6.25 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Cilacar TC 6.25 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Cilacar TC 6.25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Cilacar TC 6.25 Tablet safe for pregnant women?
Cilacar Tc has little to no side effects in pregnant women.
Is the use of Cilacar TC 6.25 Tablet safe during breastfeeding?
Cilacar Tc may have very limited harmful effects for breastfeeding women.
What is the effect of Cilacar TC 6.25 Tablet on the Kidneys?
Cilacar Tc rarely affects the kidneys.
What is the effect of Cilacar TC 6.25 Tablet on the Liver?
Cilacar Tc has very mild side effects on the liver.
What is the effect of Cilacar TC 6.25 Tablet on the Heart?
Very few cases of side effects of Cilacar Tc on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Cilacar TC 6.25 Tablet unless your doctor advises you to do so -
Is this Cilacar TC 6.25 Tablet habit forming or addictive?
Cilacar TC 6.25 Tablet does not cause addiction.
Interaction between Food and Cilacar TC 6.25 Tablet
Cilacar TC 6.25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Cilacar TC 6.25 Tablet
Taking alcohol with Cilacar TC 6.25 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448